A detailed history of Israel Englander (Millennium Management LLC) transactions in Rezolute, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 221,451 shares of RZLT stock, worth $947,810. This represents 0.0% of its overall portfolio holdings.

Number of Shares
221,451
Previous 17,651 1154.61%
Holding current value
$947,810
Previous $75,000 1332.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.13 - $5.31 $841,694 - $1.08 Million
203,800 Added 1154.61%
221,451 $1.07 Million
Q2 2024

Aug 14, 2024

SELL
$2.29 - $5.79 $7,472 - $18,892
-3,263 Reduced 15.6%
17,651 $75,000
Q1 2024

May 15, 2024

BUY
$0.95 - $2.55 $2,560 - $6,872
2,695 Added 14.79%
20,914 $53,000
Q4 2023

Feb 14, 2024

BUY
$0.74 - $1.24 $13,482 - $22,591
18,219 New
18,219 $18,000
Q4 2022

Feb 14, 2023

BUY
$1.38 - $2.84 $21,525 - $44,298
15,598 New
15,598 $32,000

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $166M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.